Big Business Models Are Back-to-Front Create Long-term Value By Putting Shareholders At the Back-end of Cash Flow Distribution

By Paul Strebel

Large firms have been treating their shareholders as their most critical stakeholders. In the short run this might make sense, but not in the long term. The author argues that in order to safeguard and increase the industry’s long-term performance and cash flows, it is critical that big business starts to identify their critical stakeholders and adapt their mission.

 

President Trump has been pushing big business to give stakeholders other than their shareholders a better deal. For example, Big Pharma firms, such as Pfizer, Novartis and Merck have been persuaded to suspend price increases. Beyond giving his base something to cheer for, Trump’s attacks have highlighted a fundamental economic flaw in the business models of big business.

  Please login or register to continue reading... Registration is simple and it is free!

About the Author

Paul Strebel is Professor Emeritus of Governance and Strategy at IMD, with three decades of experience as a director and advisor to boards and top management teams of both listed and family-held companies on strategy and governance.

LEAVE A REPLY

Please enter your comment!
Please enter your name here